Bristol-Myers Squibb (BMY) Tops Q2 EPS by 1c; Raises FY11 Outlook
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $55.42 +1.32%
Revenue Growth %: -4.6%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: -4.6%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Bristol-Myers Squibb Company (NYSE: BMY) reported Q2 EPS of $0.56, $0.01 better than the analyst estimate of $0.55. Revenue for the quarter came in at $5.4 billion versus the consensus estimate of $5.04 billion.
Sees FY2011 EPS of $2.20-$2.30, versus prior guidance of $2.10-$2.20 and the consensus of $2.21.
Sees FY2011 EPS of $2.20-$2.30, versus prior guidance of $2.10-$2.20 and the consensus of $2.21.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026
- Jabil (JBL) Tops Q3 EPS by 8c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
